Letter
Stockpiling of raw material for oseltamivir is not justified
BMJ 2006; 332 doi: https://doi.org/10.1136/bmj.332.7534.178 (Published 19 January 2006) Cite this as: BMJ 2006;332:178- Alberto A E Bertelli, research physician (studiojh@usa.net)
- Department of Human Morphology, University of Milan, via Mangiagalli 31, 20133 Milan, Italy
Editor—Mudur reports that Roche has granted a sublicence for the production of the antiviral drug oseltamivir (Tamiflu) to an Indian company and points out that the supply of raw material, shikimic acid (extracted from the Chinese spice star anise Illicium verum …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.